Dr. Reddy’s inks drug pact with Denmark’s 7TM Pharma
March 10th, 2008 - 8:09 pm ICT by admin ( Leave a comment )
Mumbai, March 10 (IANS) Dr. Reddy’s Laboratories Ltd, one of India’s leading pharmaceutical companies, has signed an agreement with Denmark-based 7TM Pharma for developing medicines in the area of metabolic disorders. In a filing with the Bombay Stock Exchange (BSE), Dr. Reddy’s said both partners would cooperate in developing drugs and clinically testing them. Once they got a green signal from the authorities, they may licence it out to a larger pharmaceutical company for further development, said the communiqu
- Ranbaxy, Russian region sign healthcare pact - Jan 31, 2011
- Dr.Reddy's acquires JB Chemicals business in Russia - Jul 23, 2011
- Ranbaxy reports Rs.464.6 crore net loss - Nov 09, 2011
- Goose launches Artwork Manager for pharma industry - Jan 03, 2012
- India, Russia sign 29 agreements from defence to trade - Dec 22, 2010
- Surya Pharma's arm acquires US's ActivOn for $22 mn - Dec 28, 2010
- Sensex closes 151 points lower as earnings disappoint (Roundup) - Jul 20, 2011
- Supreme Court order takes toll on telecom scrips - Feb 02, 2012
- Dr. Reddy's Lab Q4 net profit down 34 percent - May 13, 2011
- Kolkata bourse eyes Rs.500 crore daily trading volume - Nov 28, 2011
- Dr. Reddy's reports 37 percent jump in profit for 2nd quarter - Oct 23, 2010
- New telecom firm promoter scrips fall, older one's gain on SC order (Lead) - Feb 02, 2012
- Lupin buys anti-cholesterol drug rights for $39 mn - Sep 29, 2009
- Nirma shareholders vote for delisting - Nov 22, 2010
- NHAI to garner Rs.10,000 crore from market for projects - Dec 26, 2011
Tags: 7tm pharma, authorities, bombay stock exchange, bse, denmark, dr reddy, drug discovery, drugs, further development, g protein coupled receptor, India, inks, medicines, metabolic disorders, mumbai, pact, pharmaceutical companies, pharmaceutical company, protein coupled receptor, research and development
